Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Peripheral Neuropathy Progression

NCT01293851 is registered in ClinicalTrials.gov with National Institute of Nursing Research (NINR) as lead sponsor.

NCT NCT01293851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01293851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Peripheral Neuropathy Progression
Lead sponsor
National Institute of Nursing Research (NINR)
Phase
Observational
Overall status
Terminated
Start date
December 22, 2010
Completion date
November 13, 2012
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neurotoxicity, peripheral neuropathic pain